drugset / Trial / NCT06627556
A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary purpose of this study is to evaluate the safety and tolerability of H021 tablets following oral administration of single and multiple ascending doses in healthy participants.
Timeline
- Start
- 2024-09-17
- Primary completion
- 2025-02-27
- Completion
- 2025-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | H021 | Unknown | 6.25 mg | Oral |
| Subject | H021 | Unknown | 12.5 mg | Oral |
| Subject | H021 | Unknown | 25 mg | Oral |
| Subject | H021 | Unknown | 50 mg | Oral |
| Subject | H021 | Unknown | 100 mg | Oral |